This site is intended for healthcare professionals

Supernus Pharma announces receipt from the FDA of a Refusal to File letter for SPN 830 a proposed treatment for Parkinson's disease.

Read time: 1 mins
Last updated:28th Jun 2021
Published:13th Nov 2020
Condition: Parkinsons
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest